Korea Pharma

R&D Fields

    • Anti-dementia drugs

      Dementia is a disease that does not have the right way to treat it right now, so there is a high need for the development of a fundamental dementia treatment.
      In Korea Pharma Co., Ltd., we are researching and developing new medicines for the treatment of dementia, which have completely different paradigm from those of existing dementia treatments, as well as new medicines that improved the treatment of existing dementia treatments.

      Anti-dementia drugs with improved therapeutic effect and convenience of taking medicine.

      We are researching and developing a dementia treatment medicine that improves convenience of taking medicine and compliance of taking medicine by applying the slow-released injectable technology developed through cooperation research development to new medicine.

      Dementia treatment medicine that can cure the fundamental factors of dementia.

      The existing dementia treatment was not able to cure the dementia fundamentally, but the KOREA PHARMA has found two kinds of dementia treatment candidates which can be the fundamental treatment of dementia.

    • major antidepressant

      A major antidepressant with a different route of administration compared to conventional products.

      For those patients who are unable to administer major antidepressant medicines through the existing route of administration, they are developing improved new medicines that are modified by injections, which makes it easier to differentiate them from existing ones. In addition, the introduction of additional new patients will facilitate market expansion. Based on this fact, we are researching and developing a new treatment for dementia.

    • Anticancer adjurvants

      Renal toxicity by anticancer drugs

      We are researching and developing adjuvants that are used as anticancer drugs as a component derived from natural materials that can reduce or inhibit adverse reactions such as renal toxicity caused by platinum-based anticancer drugs.

    • liver and pulmonary fibrosis

      Therapeutic agent for liver and pulmonary fibrosis caused by anticancer drugs

      We are researching and developing adjuvants that are used as anticancer drugs as a component derived from natural materials that can reduce or suppress adverse reactions such as liver and pulmonary fibrosis caused by platinum-based anticancer drugs.

    • Other

      Type 2 antidiabetic that greatly improves compliance of taking medicine for paitent.

      It is a natural medicine for atopic dermatitis, which is low in toxicity compared to existing products.

      Medicine of autoimmune disease, Crohn's disease.

      A natural product derived from menopausal / postmenopausal, symptomatic treatment and prevention of disease.Natural remedies for menopausal / postmenopausal symptoms and for the prevention of disease.